---
figid: PMC7397772__rcmb.2020-0106EDf1
figtitle: Apolipoprotein E (APOE) exhibits both proinflammatory and antiinflammatory
  properties
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7397772
filename: rcmb.2020-0106EDf1.jpg
figlink: pmc/articles/PMC7397772/figure/fig1/
number: F1
caption: 'Apolipoprotein E (APOE) exhibits both proinflammatory and antiinflammatory
  properties. Proinflammatory: APOE is transported through receptor-mediated endocytosis
  to aggravate asthmatic conditions by facilitating NLRP3 inflammasome activation
  to release IL-1β by macrophages (). Meanwhile, APOE promotes the inflammatory response
  by activating the TLR4/TAK1/IκKβ/NF-κB/TPL2/JNK/CXCL5 pathway in small airway epithelial
  cells (SAECs) (). Antiinflammatory: APOE and Factor H interact synergistically in
  monocytes to reduce complement activation and subsequent inflammatory response in
  atherosclerotic lesions, leading to attenuated disease states (). CXCL5 = C-X-C
  motif chemokine ligand 5; HDL = high-density lipoprotein; IκKβ = IκB kinase β; JNK = c-Jun
  N-terminal kinase; LDLR = low-density lipoprotein receptor; NLRP3 = NOD-, LRR-,
  and pyrin domain-containing 3 NLRP3; TAK1 = transforming growth factor-β–activated
  kinase 1; TLR4 = Toll-like receptor 4; TPL2 = tumor progression locus 2.'
papertitle: 'Apolipoprotein E in Asthmatic Inflammatory Response: Friend or Foe?.'
reftext: Shugang Qin, et al. Am J Respir Cell Mol Biol. 2020 Aug;63(2):141-143.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9509673
figid_alias: PMC7397772__F1
figtype: Figure
redirect_from: /figures/PMC7397772__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7397772__rcmb.2020-0106EDf1.html
  '@type': Dataset
  description: 'Apolipoprotein E (APOE) exhibits both proinflammatory and antiinflammatory
    properties. Proinflammatory: APOE is transported through receptor-mediated endocytosis
    to aggravate asthmatic conditions by facilitating NLRP3 inflammasome activation
    to release IL-1β by macrophages (). Meanwhile, APOE promotes the inflammatory
    response by activating the TLR4/TAK1/IκKβ/NF-κB/TPL2/JNK/CXCL5 pathway in small
    airway epithelial cells (SAECs) (). Antiinflammatory: APOE and Factor H interact
    synergistically in monocytes to reduce complement activation and subsequent inflammatory
    response in atherosclerotic lesions, leading to attenuated disease states ().
    CXCL5 = C-X-C motif chemokine ligand 5; HDL = high-density lipoprotein; IκKβ = IκB
    kinase β; JNK = c-Jun N-terminal kinase; LDLR = low-density lipoprotein receptor;
    NLRP3 = NOD-, LRR-, and pyrin domain-containing 3 NLRP3; TAK1 = transforming growth
    factor-β–activated kinase 1; TLR4 = Toll-like receptor 4; TPL2 = tumor progression
    locus 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP1
  - modSP
  - LpR2
  - mgl
  - Myd88
  - ap
  - apo
  - Ae
  - Tak1
  - IKKbeta
  - Hdl
  - Dif
  - dl
  - Rel
  - bsk
  - Toll-4
  - APOE
  - LDLR
  - MYD88
  - MAP3K7
  - NR2C2
  - IKBKB
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - CLU
  - NLRP3
  - NFKB1
  - MAP3K8
  - MAPK8
  - MAPK9
  - MAPK10
  - CXCL5
  - IL1B
  - TLR4
---
